The right ventricle in pulmonary arterial hypertension: disorders of metabolism, angiogenesis and adrenergic signaling in right ventricular failure.
about
Cellular and molecular basis of RV hypertrophy in congenital heart diseaseCardiovascular imaging: what have we learned from animal models?Right ventricular adaptation and failure in pulmonary arterial hypertension.World Health Organization Group I Pulmonary Hypertension: Epidemiology and Pathophysiology.MECHANISMS UNDERLYING ACTION OF XINMAILONG INJECTION, A TRADITIONAL CHINESE MEDICINE IN CARDIAC FUNCTION IMPROVEMENT.Plasma acylcarnitines are associated with pulmonary hypertension.Dysfunctional BMPR2 signaling drives an abnormal endothelial requirement for glutamine in pulmonary arterial hypertensionExpression profile of matricellular proteins in hypertrophied right ventricle of monocrotaline-induced pulmonary hypertensive rats.Restoration of impaired endothelial myocyte enhancer factor 2 function rescues pulmonary arterial hypertension.Soluble guanylate cyclase: a new therapeutic target for pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.Mitochondrial integrity in a neonatal bovine model of right ventricular dysfunctionMitochondrial dynamics in pulmonary arterial hypertension.Estradiol improves right ventricular function in rats with severe angioproliferative pulmonary hypertension: effects of endogenous and exogenous sex hormones.Effects of ranolazine on exercise capacity, right ventricular indices, and hemodynamic characteristics in pulmonary arterial hypertension: a pilot studyAltered mTOR and Beclin-1 mediated autophagic activation during right ventricular remodeling in monocrotaline-induced pulmonary hypertension.Right Ventricular Angiogenesis is an Early Adaptive Response to Chronic Hypoxia-Induced Pulmonary Hypertension.The myocardial architecture changes in persistent pulmonary hypertension of the newborn in an ovine animal modelEstrogen maintains mitochondrial content and function in the right ventricle of rats with pulmonary hypertension.Evolving targeted therapies for right ventricular failure.Riociguat for the treatment of pulmonary hypertension.Soluble Guanylate Cyclase Stimulators and Activators: Novel Therapies for Pulmonary Vascular Disease or a Different Method of Increasing cGMP?Novel putative pharmacological therapies to protect the right ventricle in pulmonary hypertension: a review of current literature.Trapped lung secondary to cardiomegaly in a 78 year-old male with congestive heart failure.Bone Morphogenic Protein Type 2 Receptor Mutation-Independent Mechanisms of Disrupted Bone Morphogenetic Protein Signaling in Idiopathic Pulmonary Arterial Hypertension.Regional septal hinge-point injury contributes to adverse biventricular interactions in pulmonary hypertensionThe effects of exercise on right ventricular contractility and right ventricular-arterial coupling in pulmonary hypertension.Stem cell therapy for the systemic right ventricle.17β-Estradiol mediates superior adaptation of right ventricular function to acute strenuous exercise in female rats with severe pulmonary hypertension.It is time to look at heart failure with preserved ejection fraction from the right side.Assessment of right ventricular metabolism: An emerging tool for monitoring pulmonary artery hypertension.Natural Antioxidants as Potential Therapy, and a Promising Role for Melatonin Against Pulmonary Hypertension.Transglutaminase 2 in pulmonary and cardiac tissue remodeling in experimental pulmonary hypertension.Adenosine Receptors As Drug Targets for Treatment of Pulmonary Arterial Hypertension.Wave Intensity Analysis Provides Novel Insights Into Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension.Colchicine Depolymerizes Microtubules, Increases Junctophilin-2, and Improves Right Ventricular Function in Experimental Pulmonary Arterial Hypertension.Impact of sickle cell anaemia on cardiac chamber size in the paediatric population.Right Ventricular Fiber Structure as a Compensatory Mechanism in Pressure Overload: A Computational Study.Therapeutic Targeting of the Pyruvate Dehydrogenase Complex/Pyruvate Dehydrogenase Kinase (PDC/PDK) Axis in Cancer.Mechanisms of right heart disease in pulmonary hypertension (2017 Grover Conference Series).Fibroblasts and the extracellular matrix in right ventricular disease.
P2860
Q26777913-7B03ABB5-0BB5-4980-BE61-C59873158A87Q26779676-0B10130B-7EED-4315-B302-C570F82891C5Q27318422-0D307F99-4EFE-4ECD-8A15-9546EC2FC61CQ30248878-B288F147-F515-4AE9-A342-559E31E8041EQ33732905-8D5638B8-7749-47B9-8615-A11BBC8DC77CQ33738636-B7E777B0-316E-4010-9EAF-B191307B43ADQ33738642-BEE9A9D6-CD5D-4700-BBF1-FEF7B91BCD11Q33844110-D8A3D7EC-1A48-4CEE-99FD-E8A895797FCCQ34945488-826E5A33-42F1-4982-9857-3CFF7F825A9AQ35075847-485131D5-A445-425C-B7D2-EBBFEE15749DQ35115867-1E5F195C-A3EF-4BF0-BA56-7C578DCE1164Q35116543-3B188585-C7DE-433D-B463-A1DCBD892B8FQ35574717-745F3B34-F2D0-46AD-9E07-48CDEFAAC60BQ36016535-2037CBD8-C860-4A01-B71D-2653D37B034FQ36322517-E6BE7E3F-8A8D-4B2B-84AA-30E40C2101ECQ36470065-2E04500D-4EA3-4597-9D51-9CF89FBEB8E7Q36813671-54D1AB83-33D5-48FF-8408-33A8C74530D2Q37727384-D3EE4A37-4DAA-4899-A944-832EAD880625Q38559308-59F20CB2-484D-463E-B5BE-CD43CDA1A61DQ38645382-B41F55D8-21DF-471C-B9CA-7D7BB58FC91CQ38818645-101A31B2-DAED-4DD9-AB10-91933F36D9CEQ39093828-C53F20CB-C277-40BE-9FCA-78C2E8158FF5Q39325584-C7405414-147E-4177-AEA6-3BE0BD471839Q39760107-78197471-7837-4896-A00B-E07E1DAC82DBQ41160422-06FBAA00-8DA4-400D-969B-36998FA6108BQ41358777-80FE649E-B0ED-49AA-B7C6-A57E6C8D14FAQ41997705-62519B2E-E6BB-4FAF-B75E-13EE341C49F7Q42356930-9A12AE7F-7AB6-4E0D-A6CD-1B9B0C7C2839Q42416077-2E57D1D4-475B-4955-B0E9-D2070F9672F5Q44908617-D838132F-C2FC-4625-A02C-45CDF4E45EBBQ46183692-429058D2-7141-481E-B6C0-F7551726CD0FQ46273115-68A9B57D-FA42-48EF-A3A1-BB30DDE8177EQ47130813-9E3B204A-62E0-4392-9DF4-B416095A16EEQ47152075-80993A42-39A3-4F2D-A53D-30E1C27BC16BQ47155453-4614E7A8-5A69-48FC-8B4A-CB190D435B3DQ47258475-E3E73A34-7A1D-4A2F-90EE-C59BAF77FED5Q47578711-20E2C0EB-7D97-4DB2-AEE2-71E16ED85293Q47615969-C89AC290-F322-44B0-A986-A91067CD8BB6Q47674512-2BEB256B-CB67-46B2-B3AB-4CA622B96995Q47731267-730C8B2F-1B96-447D-98DA-379BDE120C5A
P2860
The right ventricle in pulmonary arterial hypertension: disorders of metabolism, angiogenesis and adrenergic signaling in right ventricular failure.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
The right ventricle in pulmona ...... in right ventricular failure.
@ast
The right ventricle in pulmona ...... in right ventricular failure.
@en
type
label
The right ventricle in pulmona ...... in right ventricular failure.
@ast
The right ventricle in pulmona ...... in right ventricular failure.
@en
prefLabel
The right ventricle in pulmona ...... in right ventricular failure.
@ast
The right ventricle in pulmona ...... in right ventricular failure.
@en
P2860
P1433
P1476
The right ventricle in pulmona ...... in right ventricular failure.
@en
P2093
John J Ryan
Stephen L Archer
P2860
P304
P356
10.1161/CIRCRESAHA.113.301129
P577
2014-06-01T00:00:00Z